These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16301554)

  • 21. In utero hematopoietic stem cell transplantation. A status report.
    Flake AW; Zanjani ED
    JAMA; 1997 Sep; 278(11):932-7. PubMed ID: 9302247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
    Nakamura R; Rodriguez R; Palmer J; Stein A; Naing A; Tsai N; Chang K; Slovak ML; Bhatia R; Spielberger R; Kogut N; Pullarkat V; Kirschbaum M; Forman SJ; O'Donnell MR
    Bone Marrow Transplant; 2007 Nov; 40(9):843-50. PubMed ID: 17724447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen.
    Tolar J; Bonfim C; Grewal S; Orchard P
    Bone Marrow Transplant; 2006 Dec; 38(12):783-7. PubMed ID: 17086207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent progress in pediatric stem cell transplantation].
    Matsumoto K; Kato K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):187-93. PubMed ID: 17301525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
    Blau IW; Schmidt-Hieber M; Leschinger N; Göldner H; Knauf W; Hopfenmüller W; Thiel E; Blau O
    Ann Hematol; 2007 Aug; 86(8):583-9. PubMed ID: 17468869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-myeloablative transplant of hematopoietic precursor cells. Myth and reality].
    Gómez-Almaguer D; Ruiz-Argüelles GJ; Gutiérrez-Aguirre CH; Jaime-Pérez JC
    Rev Invest Clin; 2005; 57(2):291-7. PubMed ID: 16524070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correction of fatal genetic diseases using bone marrow transplantation. 1].
    Zintl F; Hermann J; Fuchs D; Prager J; Müller A; Reiners B; Füller J
    Kinderarztl Prax; 1991; 59(1-2):6-9. PubMed ID: 2056664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
    Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
    Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
    Handgretinger R; Kurtzberg J; Egeler RM
    Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.
    Boelens JJ; Prasad VK; Tolar J; Wynn RF; Peters C
    Pediatr Clin North Am; 2010 Feb; 57(1):123-45. PubMed ID: 20307715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
    Urbano-Ispizua A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of hematologic disorders with stem cell transplantation].
    Hirai H
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():141-6. PubMed ID: 11989254
    [No Abstract]   [Full Text] [Related]  

  • 34. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency.
    Takahashi D; Nagatoshi Y; Saito Y; Inagaki J; Nagayama J; Shinkoda Y; Fujita K; Okamura J
    Bone Marrow Transplant; 2006 Apr; 37(8):807-8. PubMed ID: 16532019
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogeneic haematopoietic stem cell transplantation: current status and future outlook.
    Aschan J
    Br Med Bull; 2006; 77-78():23-36. PubMed ID: 16968691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
    Horn B; Baxter-Lowe LA; Englert L; McMillan A; Quinn M; Desantes K; Cowan M
    Bone Marrow Transplant; 2006 Feb; 37(3):263-9. PubMed ID: 16327813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies.
    Booth C; Ribeil JA; Audat F; Dal-Cortivo L; Veys PA; Thrasher AJ; Davies EG; Lefrère F; Fischer A; Cavazzana-Calvo M; Gaspar HB
    Br J Haematol; 2006 Nov; 135(4):533-7. PubMed ID: 17054675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.